Kyle Brewer

Kyle Brewer is an accomplished scientist and entrepreneur with extensive experience in drug delivery, biotechnology, and molecular biophysics. Currently serving as the Associate Director of Advanced Drug Delivery and Regenerative Biomaterials at Stanford University, Brewer focuses on developing innovative drugs and materials to enhance human health. As a Co-Founder of ETTA Biotechnology, Brewer played a crucial role in creating AI-designed small molecules aimed at addressing aging and chronic diseases. Previous positions include Scientist at Rejuvenation Technologies Inc., where over 100 novel preclinical mRNA therapies were designed, and Postdoctoral Fellow at Stanford University, where significant advancements in tracking proteins across the blood-brain barrier were made. Brewer holds a PhD in Molecular Biophysics from UT Southwestern Medical Center and dual degrees in Biochemistry and Chemistry from North Carolina State University.